These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6437723)

  • 1. Plasma nitroglycerin concentrations and hemodynamic effects of sublingual, ointment, and controlled-release forms of nitroglycerin.
    Curry SH; Kwon HR; Perrin JH; Culp JR; Pepine CJ; Yu WC; Stevens JL
    Clin Pharmacol Ther; 1984 Dec; 36(6):765-72. PubMed ID: 6437723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitroglycerin concentration in plasma: comparison between transdermal therapeutic system and ointment.
    Chu LC; Gale RM; Schmitt LG; Shaw JE
    Angiology; 1984 Sep; 35(9):545-52. PubMed ID: 6435484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of nitroglycerin generated by three nitroglycerin patch preparations, Nitradisc, Transiderm-Nitro and Nitro-Dur and one ointment formulation, Nitrobid.
    McAllister A; Mosberg H; Settlage JA; Steiner JA
    Br J Clin Pharmacol; 1986 Apr; 21(4):365-9. PubMed ID: 3085698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic-hemodynamic studies of transdermal nitroglycerin in congestive heart failure.
    Armstrong PW
    J Am Coll Cardiol; 1987 Feb; 9(2):420-5. PubMed ID: 3100600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma nitroglycerin levels after sublingual, oral and topical administration.
    Blumenthal HP; Fung HL; McNiff EF; Yap SK
    Br J Clin Pharmacol; 1977 Apr; 4(2):241-2. PubMed ID: 405030
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmaceutical considerations of transdermal nitroglycerin delivery: the various approaches.
    Chien YW
    Am Heart J; 1984 Jul; 108(1):207-16. PubMed ID: 6428207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of a new transdermal nitroglycerin adhesive patch formulation.
    Riedel DJ; Wick KA; Hawkinson RW; Kolars CA; Crowley JK; Armstrong KE; Chang SF; Harrison LI; de Dennis SR
    Clin Ther; 1989; 11(2):225-31. PubMed ID: 2500248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulatory effects of sublingual and oral sustained-release nitroglycerin in healthy young men.
    Nyberg G; Westling H
    Eur J Clin Pharmacol; 1981 Mar; 19(4):245-9. PubMed ID: 6793373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Responsiveness of peripheral veins to transdermal and sublingual nitroglycerin in healthy male volunteers.
    Hiremath AN; Hoffman BB; Blaschke TF
    J Cardiovasc Pharmacol; 1989 Oct; 14(4):534-41. PubMed ID: 2478766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variable glyceryl dinitrate formation as a function of route of nitroglycerin administration.
    Noonan PK; Benet LZ
    Clin Pharmacol Ther; 1987 Sep; 42(3):273-7. PubMed ID: 3113806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetics and relative bioavailability of a nitroglycerin ointment formulation (author's transl)].
    Maier-Lenz H; Ringwelski L; Windorfer A
    Arzneimittelforschung; 1980; 30(2):320-4. PubMed ID: 6769443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal nitroglycerin ointment and patches.
    Todd B
    Geriatr Nurs; 1986; 7(3):152-4. PubMed ID: 3084347
    [No Abstract]   [Full Text] [Related]  

  • 13. Topical nitroglycerin. A safeguard against pressor responses to tracheal intubation.
    Kamra S; Wig J; Sapru RP
    Anaesthesia; 1986 Nov; 41(11):1087-91. PubMed ID: 3098132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the safety and efficacy of topical nitroglycerin ointment to facilitate venous cannulation.
    Griffith P; James B; Cropp A
    Nurs Res; 1994; 43(4):203-6. PubMed ID: 8047423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application site for nitroglycerin ointment.
    Hansen MS
    Am J Cardiol; 1978 Dec; 42(6):1061. PubMed ID: 103418
    [No Abstract]   [Full Text] [Related]  

  • 16. Transdermal nitroglycerin as a step 3 antihypertensive drug.
    Simon G; Wittig VJ; Cohn JN
    Clin Pharmacol Ther; 1986 Jul; 40(1):42-5. PubMed ID: 3087678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of nitroglycerin ointment.
    Elliott WC
    J Indiana State Med Assoc; 1974 Feb; 67(2):99-103. PubMed ID: 4204690
    [No Abstract]   [Full Text] [Related]  

  • 18. [Haemodynamic effects after application of nitroglycerin sublingually or as ointment in patients with left ventricular heart failure (author's transl)].
    Magometschnigg D; Bonelli J; Gassner A; Lenzhofer R; Kleinberger G; Pall H; Pichler M
    Wien Klin Wochenschr; 1980 Jan; 92(1):24-6. PubMed ID: 6769256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitroglycerin ointment: a review.
    Francis GS; Hagan AD
    Angiology; 1977 Dec; 28(12):873-8. PubMed ID: 414640
    [No Abstract]   [Full Text] [Related]  

  • 20. [Nitroglycerin ointment v.s. sublingual nitroglycerin on peripheral venomotricity in man (author's transl)].
    Berdeaux A; Duhaze P; Giudicelli JF
    Nouv Presse Med; 1980 Sep; 9(34 Suppl):2455-7. PubMed ID: 6775298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.